TIGIT and chronic myelogenous leukemia, BCR-ABL1 positive: Next, we compared the expression of CD38, CD69, HLA-DR, CD28, CD57, BTLA, TIGIT, and PD-1 on the CD4+ and CD8+ T subsets in PB for each CML group.